Growth Metrics

ImmunityBio (IBRX) Net Cash Flow (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 316.09%
Dec 31, 2025 136.62%
Sep 30, 2025 -199.77%
Jun 30, 2025 192.89%
Mar 31, 2025 -361.74%
Dec 31, 2024 274.22%
Sep 30, 2024 -516.68%
Jun 30, 2024 97.78%
Mar 31, 2024 -251.26%
Dec 31, 2023 -34.92%
Sep 30, 2023 399.05%
Jun 30, 2023 -182.69%
Mar 31, 2023 -5,086.21%
Dec 31, 2022 -99.24%
Sep 30, 2022 66.18%
Jun 30, 2022 117.58%
Mar 31, 2022 -224.06%
Dec 31, 2021 698.17%
Sep 30, 2021 -149.65%
Jun 30, 2021 297.36%
Mar 31, 2021 119.82%
Dec 31, 2020 -63.88%
Sep 30, 2020 -153.72%
Jun 30, 2020 428.34%
Mar 31, 2020 16.93%
Dec 31, 2019 -2,822.83%
Sep 30, 2019 112.81%
Jun 30, 2019 -189.37%
Mar 31, 2019 340.64%
Dec 31, 2018 286.08%
Sep 30, 2018 -116.48%
Jun 30, 2018 138.86%
Mar 31, 2018 -529.40%
Dec 31, 2017 116.29%
Sep 30, 2017 -171.21%
Jun 30, 2017 361.51%
Mar 31, 2017 123.64%
Dec 31, 2016 -242.00%
Sep 30, 2016 72.75%
Jun 30, 2016 77.78%
Mar 31, 2016 38.36%
Dec 31, 2015 -176.72%
Sep 30, 2015 237.52%
Jun 30, 2015 863.06%
Mar 31, 2015 -116.54%
Dec 31, 2014 6,970.39%
Sep 30, 2014 60.71%
Jun 30, 2014 -5,655.56%